These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 15979441)

  • 1. Acute effect of atorvastatin on coronary circulation measured by transthoracic Doppler echocardiography in patients without coronary artery disease by angiography.
    Hinoi T; Matsuo S; Tadehara F; Tsujiyama S; Yamakido M
    Am J Cardiol; 2005 Jul; 96(1):89-91. PubMed ID: 15979441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of low-dose atorvastatin on lipid levels and endothelial vascular function in patients with significant coronary artery stenosis.
    Kuryata OV; Yegorova YV
    Kardiol Pol; 2006 Jan; 64(1):44-8; discussion 49-50. PubMed ID: 16444629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of atorvastatin on coronary flow reserve in patients with slow coronary flow.
    Caliskan M; Erdogan D; Gullu H; Topcu S; Ciftci O; Yildirir A; Muderrisoglu H
    Clin Cardiol; 2007 Sep; 30(9):475-9. PubMed ID: 17803205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of atorvastatin on cognitive function in patients from the Lipid Lowering and Onset of Renal Disease (LORD) trial.
    Summers MJ; Oliver KR; Coombes JS; Fassett RG
    Pharmacotherapy; 2007 Feb; 27(2):183-90. PubMed ID: 17253908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of atorvastatin (10 mg) on hemostatic and inflammatory parameters in hyperlipidemic patients with angiographically proven coronary artery disease.
    Tekin A; Tekin G; Güzelsoy D; Kaya A; Gürel CV; Yiğit Z; Ulutin T
    Am J Cardiol; 2004 Jul; 94(2):206-9. PubMed ID: 15246903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined use of extended-release niacin and atorvastatin: safety and effects on lipid modification.
    Sang ZC; Wang F; Zhou Q; Li YH; Li YG; Wang HP; Chen SY
    Chin Med J (Engl); 2009 Jul; 122(14):1615-20. PubMed ID: 19719960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibitory potency of clopidogrel on ADP-induced platelet activation is not attenuated when it is co-administered with atorvastatin (20 mg/day) for 5 weeks in patients with acute coronary syndromes.
    Mitsios JV; Papathanasiou AI; Elisaf M; Goudevenos JA; Tselepis AD
    Platelets; 2005 Aug; 16(5):287-92. PubMed ID: 16011979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of ezetimibe added on to atorvastatin (40 mg) compared with uptitration of atorvastatin (to 80 mg) in hypercholesterolemic patients at high risk of coronary heart disease.
    Leiter LA; Bays H; Conard S; Bird S; Rubino J; Hanson ME; Tomassini JE; Tershakovec AM
    Am J Cardiol; 2008 Dec; 102(11):1495-501. PubMed ID: 19026303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atorvastatin treatment improves myocardial and peripheral blood flow in familial hypercholesterolemia subjects without evidence of coronary atherosclerosis.
    Lario FC; Miname MH; Tsutsui JM; Santos RD; Kowatsch I; Sbano JC; Ramires JA; Kalil Filho R; Mathias W
    Echocardiography; 2013 Jan; 30(1):64-71. PubMed ID: 22957727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of ezetimibe added on to atorvastatin (20 mg) versus uptitration of atorvastatin (to 40 mg) in hypercholesterolemic patients at moderately high risk for coronary heart disease.
    Conard SE; Bays HE; Leiter LA; Bird SR; Rubino J; Lowe RS; Tomassini JE; Tershakovec AM
    Am J Cardiol; 2008 Dec; 102(11):1489-94. PubMed ID: 19026302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of statin treatment in men and women with stable coronary heart disease: a subgroup analysis of the GREACE Study.
    Athyros VG; Kakafika AI; Papageorgiou AA; Paraskevas KI; Tziomalos K; Anagnostis P; Pagourelias E; Koumaras C; Karagiannis A; Mikhailidis DP
    Curr Med Res Opin; 2008 Jun; 24(6):1593-9. PubMed ID: 18430270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of atorvastatin on left ventricular diastolic function and ability of coenzyme Q10 to reverse that dysfunction.
    Silver MA; Langsjoen PH; Szabo S; Patil H; Zelinger A
    Am J Cardiol; 2004 Nov; 94(10):1306-10. PubMed ID: 15541254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months: a multicenter, randomized, double-blind trial.
    Schmermund A; Achenbach S; Budde T; Buziashvili Y; Förster A; Friedrich G; Henein M; Kerkhoff G; Knollmann F; Kukharchuk V; Lahiri A; Leischik R; Moshage W; Schartl M; Siffert W; Steinhagen-Thiessen E; Sinitsyn V; Vogt A; Wiedeking B; Erbel R
    Circulation; 2006 Jan; 113(3):427-37. PubMed ID: 16415377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [To lessen the cardiovascular risk of the diabetic patient. Atorvastatin of use for diabetic patients without coronary disease, too].
    MMW Fortschr Med; 2005 Aug; 147(33-34):51. PubMed ID: 16138641
    [No Abstract]   [Full Text] [Related]  

  • 15. Pregnancy-associated plasma protein-A elevation in patients with acute coronary syndrome and subsequent atorvastatin therapy.
    Miedema MD; Conover CA; MacDonald H; Harrington SC; Oberg D; Wilson D; Henry TD; Schwartz RS
    Am J Cardiol; 2008 Jan; 101(1):35-9. PubMed ID: 18157962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of atorvastatin and pravastatin on glucose tolerance, adipokine levels and inflammatory markers in hypercholesterolaemic patients.
    Ando H; Sugimoto K; Yanagihara H; Tsuruoka S; Saito T; Takamura T; Kaneko S; Fujimura A
    Clin Exp Pharmacol Physiol; 2008 Sep; 35(9):1012-7. PubMed ID: 18430053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atorvastatin therapy improves exercise oxygen uptake kinetics in post-myocardial infarction patients.
    Guazzi M; Tumminello G; Reina G; Vicenzi M; Guazzi MD
    Eur J Clin Invest; 2007 Jun; 37(6):454-62. PubMed ID: 17537152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein modifying effects of statins and fibrate in various age groups of coronary artery disease patients.
    Sharma R; Mahajan M; Singh B; Bal BS; Kant R
    J Indian Med Assoc; 2006 Sep; 104(9):492-4, 496, 498. PubMed ID: 17388006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atorvastatin may have no effect on acute phase reaction in children after intravenous bisphosphonate infusion.
    Srivastava T; Haney CJ; Alon US
    J Bone Miner Res; 2009 Feb; 24(2):334-7. PubMed ID: 18847329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Coronary flow reserve assessment by transthoracic color Doppler echocardiography after primary angioplasty: relationship with recovery of left ventricular function].
    Pezzano A; Valentini M; Comerio G; Tavanelli M; Racca V; Brambilla G; Ferratini M
    Ital Heart J Suppl; 2005 Oct; 6(10):660-6. PubMed ID: 16273753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.